Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sainan Hu
Observed name:
SAI-NAN HU
Institution:
Hunan Provincial Maternal and Child Health Hospital
Observed institutions:
Sheng Jing Hospital,
Jiangsu Cancer Hospital,
Hunan Provincial Maternal and Child Health Hospital,
Nanjing Medical University
ORCID:
0000-0001-7389-3629
Observed ORCID:
0000-0001-7389-3629
OpenAlex ID:
A5000748150
Mitophagy in ototoxicity
2023
·
Hezhou Han
, Sainan Hu
, et al.
·
Frontiers in Cellular Neuroscience
·
15
PDF
RETRACTED ARTICLE: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
2020
·
Jin Gao
, Yuan Yuan
, et al.
·
Cancer Cell International
·
14
PDF
Correlation between polymorphisms of nicotine acetylcholine acceptor subunit CHRNA3 and lung cancer susceptibility
2012
·
BO SHEN
, MEI-QI SHI
, et al.
·
Molecular Medicine Reports
·
6
PDF
Retraction Note to: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
2021
·
Jin Gao
, Yuan Yuan
, et al.
·
Cancer Cell International
·
2
PDF
CUL1 variants cause severe neurodevelopmental disorders: Insights from human genetics and a zebrafish model of microcephaly
2025
·
Haoling Xu
, Zhen Liu
, et al.
·
Human Genetics and Genomics Advances
·
1
A phase II trial of anlotinib combined chemotherapy as second-line and above therapy in HER2-negative advanced breast cancer.
2024
·
Yuan Yuan
, Lili Zhang
, et al.
·
Journal of Clinical Oncology
·
1
Show more works
View as search
Works count:
6
Citation count:
39
H-index:
3
I10-index:
2
Year
Topic
Type